Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Experimental analysis of conditioning factors in human narcotic addiction.

O'Brien CP.

Pharmacol Rev. 1975 Dec;27(4):533-43. No abstract available.

PMID:
1223916
[PubMed - indexed for MEDLINE]
2.

Conditioning of narcotic abstinence symptoms in human subjects.

O'Brien CP, O'Brien TJ, Mintz J, Brady JP.

Drug Alcohol Depend. 1975 Dec;1(2):115-23.

PMID:
1235105
[PubMed - indexed for MEDLINE]
3.

Reliability of sequential naloxone challenge tests.

Rosen MI, McMahon TJ, Margolin A, Gill TS, Woods SW, Pearsall HR, Kreek MJ, Kosten TR.

Am J Drug Alcohol Abuse. 1995 Nov;21(4):453-67.

PMID:
8561097
[PubMed - indexed for MEDLINE]
4.

Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.

Ho AK, Chen RC.

Ann N Y Acad Sci. 1976;281:297-310. No abstract available.

PMID:
1071365
[PubMed - indexed for MEDLINE]
5.

Conditioned narcotic withdrawal in humans.

O'Brien CP, Testa T, O'Brien TJ, Brady JP, Wells B.

Science. 1977 Mar 11;195(4282):1000-2.

PMID:
841320
[PubMed - indexed for MEDLINE]
6.

Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.

Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Rubinstein KJ.

J Pharmacol Exp Ther. 1992 Jan;260(1):355-63.

PMID:
1731046
[PubMed - indexed for MEDLINE]
7.

Conditioning in human opiate addicts.

O'Brien CP, Testa T, O'Brien TJ, Greenstein R.

Pavlov J Biol Sci. 1976 Oct-Dec;11(4):195-202.

PMID:
995439
[PubMed - indexed for MEDLINE]
8.

Buprenorphine and naloxone interactions in methadone maintenance patients.

Mendelson J, Jones RT, Welm S, Brown J, Batki SL.

Biol Psychiatry. 1997 Jun 1;41(11):1095-101.

PMID:
9146820
[PubMed - indexed for MEDLINE]
9.

Narcotic poisoning: an epidemic disease.

Kersh ES, Schwartz LK.

Am Fam Physician. 1973 Dec;8(6):90-7. No abstract available.

PMID:
4760436
[PubMed - indexed for MEDLINE]
10.

Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline.

Preston KL, Bigelow GE, Stitzer ML, Liebson IA.

NIDA Res Monogr. 1984;55:151-7. No abstract available.

PMID:
6085768
[PubMed - indexed for MEDLINE]
11.

Dose dependent effects of yohimbine on methadone maintained patients.

Hameedi FA, Woods SW, Rosen MI, Pearsall HR, Kosten TR.

Am J Drug Alcohol Abuse. 1997 May;23(2):327-33.

PMID:
9143642
[PubMed - indexed for MEDLINE]
12.

Effects of narcotics and narcotic antagonists on operant behavior.

McMillan DE.

Adv Biochem Psychopharmacol. 1973;8(0):345-59. Review. No abstract available.

PMID:
4604406
[PubMed - indexed for MEDLINE]
13.

Rating the presence and severity of opiate dependence.

Wang RI, Wiesen RL, Lamid S, Roh BL.

Clin Pharmacol Ther. 1974 Oct;16(4):653-8. No abstract available.

PMID:
4422361
[PubMed - indexed for MEDLINE]
14.

Reinstatement of precipitated narcotic withdrawal hypothermia in the rat.

Ary M, Lomax P.

Life Sci. 1976 Jun 1;18(11):1199-202. No abstract available.

PMID:
945438
[PubMed - indexed for MEDLINE]
15.

Pain perception in drug-free and in methadone-maintained human ex-addicts.

Ho A, Dole VP.

Proc Soc Exp Biol Med. 1979 Dec;162(3):392-5. No abstract available.

PMID:
515020
[PubMed - indexed for MEDLINE]
16.

Intermittent naloxone attenuates the development of physical dependence on methadone in rhesus monkeys.

Krystal JH, Walker MW, Heninger GR.

Eur J Pharmacol. 1989 Feb 7;160(3):331-8.

PMID:
2540995
[PubMed - indexed for MEDLINE]
17.

Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.

Charney DS, Redmond DE Jr, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH.

Life Sci. 1984 Sep 17;35(12):1263-72.

PMID:
6482651
[PubMed - indexed for MEDLINE]
18.

Blockade with methadone, cyclazocine, and naloxone.

Freedman AM, Zaks A, Resnick R, Fink M.

Int J Addict. 1970 Sep;5(3):507-15. No abstract available.

PMID:
5524385
[PubMed - indexed for MEDLINE]
19.

Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.

Wikler A.

Adv Biochem Psychopharmacol. 1973;8(0):399-414. No abstract available.

PMID:
4795072
[PubMed - indexed for MEDLINE]
20.

Preliminary experiences with the treatment of opiate addiction by methadone withdrawal.

Gudeman JE, Shader RI, Ryan J, Rolde EJ.

Conn Med. 1972 Mar;36(3):137-42. No abstract available.

PMID:
5012267
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk